These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2896636

  • 21. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
    Arcimowicz M, Samoliński B, Zawisza E.
    Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ, Lund VJ, Harten-Ash VJ.
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of levocabastine in conjunctival provocation studies.
    Janssens M.
    Doc Ophthalmol; 1992 Dec; 82(4):341-51. PubMed ID: 1363980
    [Abstract] [Full Text] [Related]

  • 28. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis.
    Schata M, Jorde W, Richarz-Barthauer U.
    J Allergy Clin Immunol; 1991 Apr; 87(4):873-8. PubMed ID: 1672878
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R, Saritzali G, Canakçioğlu S.
    Kulak Burun Bogaz Ihtis Derg; 2007 Apr; 17(1):30-6. PubMed ID: 17483609
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction.
    Juliusson S, Bende M.
    Rhinology; 1996 Mar; 34(1):24-7. PubMed ID: 8739864
    [Abstract] [Full Text] [Related]

  • 35. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J, Peake HL, Santos CM, Lean M, Bardin P, Robson R, Haumann B, Loehrer F, Handel ML.
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [Abstract] [Full Text] [Related]

  • 36. [Levocabastine--a new antihistaminic for local treatment].
    Larsen BB, Pedersen B, Dahl R.
    Ugeskr Laeger; 1993 Jun 28; 155(26):2070-3. PubMed ID: 8101023
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nasal histamine sensitivity in allergic rhinitis.
    Okuda M, Ohtsuka H, Sakaguchi K, Watase T.
    Ann Allergy; 1983 Jul 28; 51(1 Pt 1):51-5. PubMed ID: 6135377
    [Abstract] [Full Text] [Related]

  • 39. The role of levocabastine in the treatment of allergic rhinoconjunctivitis.
    Knight A.
    Br J Clin Pract; 1994 Jul 28; 48(3):139-43. PubMed ID: 7913336
    [Abstract] [Full Text] [Related]

  • 40. Topical levocabastine for the treatment of perennial allergic rhinitis.
    Elwany S, Bassiouny M.
    J Laryngol Otol; 1997 Oct 28; 111(10):935-40. PubMed ID: 9425481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.